Latest AI and machine learning research in diabetes for healthcare professionals.
PURPOSE: To evaluate the diagnostic performance of a regulatory-approved (CE-marked) artificial intelligence system (RetCAD) applied to nonmydriatic color fundus photographs for diabetic retinopathy (DR) screening in routine clinical care. METHODS: This was a prospective single-center observational diagnostic accuracy study including adults with diabetes who underwent nonmydriatic fundus imaging b...
Gestational diabetes mellitus (GDM) can elevate the likelihood of developing high blood pressure during pregnancy. It is one of the most common complications of pregnancy. The purpose of this study was to identify biomarkers related to mitochondria and glycometabolism in GDM and explore potential regulatory mechanisms. GDM transcriptome datasets were analyzed for differential expression to identif...
OBJECTIVES: This study aimed to systematically evaluate whether glycemic variability (GV) could provide independent incremental prognostic value for i...
Accurate and explainable classification of diabetic foot ulcers (DFUs) is vital for early intervention and patient management. This paper presents a C...
Early detection of diabetic retinopathy (DR) is crucial for preventing irreversible vision loss; however, existing automated methods often rely on sin...
Depression is a common comorbidity in individuals with diabetes and is associated with adverse clinical outcomes. Early identification of high-risk in...
Kidney stone disease (KSD) is increasingly prevalent among patients with diabetes mellitus and hypertension. Obesity-related metabolic abnormalities m...
BACKGROUND: The clinical comorbidity of diabetes mellitus (DM) and gastric cancer (GC) presents a significant healthcare challenge, as these two condi...
Type 2 diabetes and prediabetes remain substantially underrecognized, highlighting the need for practical screening approaches based on routinely avai...
The urgent need for innovative cancer therapies has driven increasing interest in repurposing drugs originally developed for non-oncological diseases....
Artificial intelligence (AI) tools in diabetic retinal screening (DRS) are currently in use overseas within public health systems, with growing eviden...
BACKGROUND: The homeless population in Bogotá exhibits complex social and health vulnerabilities, with a high prevalence of chronic and communicable d...
BACKGROUND: Diagnostics and therapeutics for corneal nerve pathologies are rapidly evolving, with continual advancements in imaging, laser, machine le...
AIMS/HYPOTHESIS: Hybrid closed-loop insulin delivery systems are increasingly regarded as the preferred therapy for type 1 diabetes, although evidence...
BACKGROUND: Long-term management of chronic diseases such as diabetes is increasingly based on wearable technologies, particularly continuous glucose ...
BACKGROUND: Identifying older home care recipients at risk of institutionalization in advance is crucial for providing preventive services. Supporting...
BACKGROUND: The stress hyperglycemia ratio (SHR) has recently been suggested as a dependable indication for predicting adverse outcomes in critically ...
ObjectiveTo evaluate the diagnostic accuracy of a multi-disease offline artificial intelligence system (Medios-AI, MAI), integrated into a smartphone-...
INTRODUCTION: Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), is a key therapy in managing type 2 diabetes (T2D), offering signific...
The rising global prevalence of diabetes mellitus and its liver complications presents a significant public health challenge. Inflammation-driven cros...